The European Commission will present different EU initiatives expected to influence access to innovation and awarding value for medical technologies, in an environment where health is a national competence. Among the most relevant initiatives expected to be presented are the EU Public Procurement Directive (DG Growth), Health System Performance and the EU cooperation on HTA (there will be a new EC legislative proposal by the end of January) (DG Sante). Besides providing an update on Commission activities, the presentations should trigger a discussion from a business perspective e.g. how these initiatives could influence the business in Europe in the next 5 years (e.g. facilitate exchange of knowledge and best practices, measure performance, change in attractiveness of Europe as first market to go to in a frame of better regulations, shift from price only driven to a value-based procurement, increase in number of assessments on medical devices, HTA as a potential tool to stimulate innovation, increased data requirements , investment ).
- To discuss how the EU initiatives are impacting your business
- To present and deepen understanding of EU initiatives relevant to the medtech sector